Kuros Biosurgery AG
Edit

Kuros Biosurgery AG

http://www.kuros.ch/
Tags:ActiveBioTechLocalMedicalMedTechPlatformProductTechnology
Kuros Biosurgery AG is a biotechnology company dedicated to developing biologics and biomaterials for local therapy within the core areas of trauma, wound and spine. The company’s products are based on a technology platform that allows the combination of natural and synthetic matrices to active molecules and ensures its controlled release thereof. Kuros Biosurgery AG has several products in clinical stages and its lead product KUR-111 met its primary efficacy endpoint in a Phase IIb study for tibial plateau fractures.
Location: Switzerland
Total raised: $81.801834M

Investors 1

Funding Rounds 7

DateSeriesAmountInvestorsDeal News
05.12.2019-$12.661984...-startuptic...
03.08.2017-$17.564051...-startuptic...
11.11.2015-$19.824454...-startuptic...
18.08.2015-$15.496556...-finsmes.co...
06.10.2005-$4.389423M-neomed.net...
06.06.2004-$4.899838M-neomed.net...
06.11.2002-$6.965528M-neomed.net...

Mentions in press and media 13

DateTitleDescriptionCategoryAuthorSource
05.12.2019Kuros rais... Kuros Biosciences is focused...Financing-startuptic...
03.08.2017Kuros rais... The new shares for the exerc...Financing-startuptic...
22.04.2016Kuros rece... In August 2015, Checkmate ac...Success-startuptic...
21.01.2016Kuros on t... Kuros Biosciences Ltd. (SIX:...Financing-startuptic...
03.12.2015Kuros and ... Cytos is listed on the main ...Financing-startuptic...
16.11.2015KUROS anno... The CHF 5 million was raised...Financing-startuptic...
11.11.2015Kuros Bios...Kuros Biosurgery AG, a Zurich,...Switzerlan...-finsmes.co...
19.08.2015Kuros anno... The financing round was led ...Financing-startuptic...
18.08.2015Kuros Bios...Kuros Biosurgery AG, a Zurich,...Switzerlan...-finsmes.co...
10.08.2012Kuros repo... KUR-023 is a synthetic hydro...--startuptic...
Show more